← FDA Drug Approvals (Drugs@FDA)

AZACITIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2017-06-23

Drug application

FDA Application #

ANDA207234

Application type

Abbreviated New Drug Application (Generic)

Brand name

AZACITIDINE

Generic name

AZACITIDINE

Active ingredients

AZACITIDINE

Dosage form

POWDER

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NATCO PHARMA LTD

Manufacturer

Panacea Biotec Limited

First approval

2017-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown